Study Group (N = 62) | Control Group (N = 59) | ||||
---|---|---|---|---|---|
Pre-Treatment | Post-Treatment (6 months) | Pre-Treatment | Post-Treatment (6 months) | p-value | |
Normal | 13 (20.9%) | 26 (41.9%) | 18 (30.5%) | 23 (39.9%) | 0.672 |
Inflammation | 31 (50%) | 30 (41.9%) | 28 (47.4%) | 26 (44.1%) | 0.365 |
ASCUS and LSIL | 13 (21.0%) | 4 (6.5%) | 9 (15.3%) | 6 (10.2%) | 0.017 |
Unsatisfactory | 5 (8.1%) | 2 (3.2%) | 4 (6.8%) | 4 (6.8%) | 0.027 |